Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Anthony J. Olszanski
NCCN Working Group Report: Designing Clinical Trials in the Era of Multiple Biomarkers and Targeted Therapies
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Phase I Study of the mTOR Inhibitor Ridaforolimus and the HDAC Inhibitor Vorinostat in Advanced Renal Cell Carcinoma and Other Solid Tumors
Investigational New Drugs
Oncology
Pharmacology
Related publications
Targeted Therapies in Cholangiocarcinoma: Emerging Evidence From Clinical Trials
Medicina
Medicine
Optimizing the Clinical Utility of Biomarkers in Oncology: The NCCN Biomarkers Compendium
Archives of Pathology and Laboratory Medicine
Medicine
Forensic Medicine
Pathology
Medical Laboratory Technology
A Systematic Review of Pediatric Phase I Trials in Oncology: Toxicity and Outcomes in the Era of Targeted Therapies
Oncologist
Cancer Research
Medicine
Oncology
Cytoreductive Nephrectomy in the Era of Targeted Therapies: A Review
BJU International
Urology
Clinical Trials of Neuroprotective Therapies
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Phase III Trials of Targeted Anticancer Therapies: Redesigning the Concept
Clinical Cancer Research
Cancer Research
Oncology
Designing Clinical Trials in Acute Kidney Injury
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Cooperative Group Cancer Clinical Trials: An NCIC Clinical Trials Group Perspective
Canadian Urological Association Journal
Urology
Clinical Trials of Ebola Therapies to Begin in December
British Medical Journal
Medicine